Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Antitumor Immunity
Authors:
- 12 January 2023
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 83 (6) , 906-921
Abstract
Sex is known to be an important factor in the incidence, progression, and outcome of cancer. A better understanding of the underlying mechanisms could help improve cancer prevention and treatment. Here, we demonstrated a crucial role of antitumor immunity in the sex differences in cancer. Consistent with observations in human cancers, male mice showed accelerated tumor progression compared with females, but these differences were not observed in immunodeficient mice. Androgen signaling suppressed T-cell immunity against cancer in males. Mechanistically, androgen-activated androgen receptor upregulated expression of USP18, which inhibited TAK1 phosphorylation and the subsequent activation of NF-κB in antitumor T cells. Reduction of testosterone synthesis by surgical castration or using the small-molecular inhibitor abiraterone significantly enhanced the antitumor activity of T cells in male mice and improved the efficacy of anti–PD-1 immunotherapy. Together, this study revealed a novel mechanism contributing to sex differences in cancer. These results indicate that inhibition of androgen signaling is a promising approach to improve the efficacy of immunotherapy in males. Significance: Androgen signaling induces immunosuppression in cancer by blocking T-cell activity through upregulation of USP18 and subsequent inhibition of NF-κB activity, providing a targetable axis to improve antitumor immunity in males.Keywords
All Related Versions
Funding Information
- National Key Research and Development Program of China (2016YFA0500304)
- National Natural Science Foundation of China (82130086, 82192892, 81773052, 81572806, 81802853, 81802854)
- Guangzhou Science, Technology and Innovation Commission (201607020038)
- Natural Science Foundation of Guangdong Province (2017A030308007)
- Guangdong Innovative and Entrepreneurial Research Team Program (2016ZT06S638)
- Leading Talents Program of Guangdong Province (2016LJ06S464)
This publication has 46 references indexed in Scilit:
- Oncology Meets Immunology: The Cancer-Immunity CycleImmunity, 2013
- USP18 inhibits NF-κB and NFAT activation during Th17 differentiation by deubiquitinating the TAK1–TAB1 complexJournal of Experimental Medicine, 2013
- Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced MelanomaJournal of Clinical Oncology, 2013
- Sex-dependent Differences in Intestinal Tumorigenesis Induced in Apc1638N/+ Mice by Exposure to γ RaysInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Peroxisome proliferator-activated receptor (PPAR)α and -γ regulate IFNγ and IL-17A production by human T cells in a sex-specific wayProceedings of the National Academy of Sciences, 2012
- Androgen Receptor Gene Expression in Prostate Cancer Is Directly Suppressed by the Androgen Receptor Through Recruitment of Lysine-Specific Demethylase 1Cancer Cell, 2011
- Contribution of smoking-related and alcohol-related deaths to the gender gap in mortality: evidence from 30 European countries: Table 1Tobacco Control, 2011
- B7-H1–Dependent Sex-Related Differences in Tumor Immunity and Immunotherapy ResponsesThe Journal of Immunology, 2010
- Sex Differences in Lung Cancer Survival: Do Tumors Behave Differently in Elderly Women?Journal of Clinical Oncology, 2007
- Androgen Deprivation Therapy for Prostate CancerJAMA, 2005